Articles from Onsera Health
The addition of Foundayo (orforglipron) provides participants with an FDA-approved, injection-free, GLP-1 treatment for people living with excess weight within a structured personalized care platform
By Onsera Health · Via ACCESS Newswire · August 5, 2026
